Biomex Instruments Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 09-01-2025
- Paid Up Capital ₹ 1.80 Cr
as on 09-01-2025
- Company Age 34 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 59.66 Cr
as on 09-01-2025
- Revenue 66.93%
(FY 2022)
- Profit -51.03%
(FY 2022)
- Ebitda -14.09%
(FY 2022)
- Net Worth 21.09%
(FY 2022)
- Total Assets 11.33%
(FY 2022)
About Biomex Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.80 Cr.
The company currently has active open charges totaling ₹59.66 Cr.
Sunil Aggarwal, Shashi Aggarwal, and Gaurav Aggarwal serve as directors at the Company.
- CIN/LLPIN
U51507CH1991PTC010989
- Company No.
010989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biomex Instruments Private Limited offer?
Biomex Instruments Private Limited offers a wide range of products and services, including Used Machinery & Tools, Refurbished Medical Equipment, CT Scan Machine, Hitachi CT Scanner, Refurbished CT Scanner, Doppler Machine, Portable Color Doppler Ultrasound Scanner, Diagnostic Medical Imaging Equipment, MRI Machine, Medical Imaging Machine & Accessories.
Who are the key members and board of directors at Biomex Instruments?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi Aggarwal | Director | 15-Jan-1991 | Current |
Gaurav Aggarwal | Director | 10-Jun-2015 | Current |
Sunil Aggarwal | Director | 15-Jan-1991 | Current |
Financial Performance of Biomex Instruments.
Biomex Instruments Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 66.93% increase. The company also saw a substantial fall in profitability, with a 51.03% decrease in profit. The company's net worth Soared by an impressive increase of 21.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biomex Instruments?
Unlock access to Biomex Instruments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Cheema Medical Complex Private LimitedActive 2 years 7 months
Sunil Aggarwal, Shashi Aggarwal and 1 more are mutual person
- Positroscint Private LimitedActive 4 years 11 months
Sunil Aggarwal, Shashi Aggarwal and 1 more are mutual person
- Dynamic Diagnostics Private LimitedActive 5 years 5 months
Sunil Aggarwal and Gaurav Aggarwal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 01 Nov 2024 | ₹2.80 M | Open |
State Bank Of India Creation Date: 01 May 2023 | ₹24.48 Cr | Open |
State Bank Of India Creation Date: 01 May 2023 | ₹25.00 Cr | Open |
How Many Employees Work at Biomex Instruments?
Biomex Instruments has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomex Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomex Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.